Methods for treating vascular leak syndrome

Details for Australian Patent Application No. 2010203352 (hide)

Owner Akebia Therapeutics Inc.

Inventors Shalwitz, Robert; Peters, Kevin Gene

Agent Griffith Hack

Pub. Number AU-A-2010203352

PCT Pub. Number WO2010/081172

Priority 61/144,022 12.01.09 US; 61/184,986 08.06.09 US

Filing date 12 January 2010

Wipo publication date 15 July 2010

International Classifications

A01N 43/82 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

Event Publications

25 August 2011 PCT application entered the National Phase

  PCT publication WO2010/081172 Priority application(s): WO2010/081172

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010203353-Modified antibody compositions, methods of making and using thereof

2010203335-Stacking structure for fiber cement building material